CMS NEWS
FOR IMMEDIATE RELEASE
November 2, 2018
Contact: CMS Media
Relations
(202) 690-6145 | CMS Media Inquiries
CMS Finalizes Rule that Encourages More Choices and Lower Costs
for Seniors
CMS Administrator Seema Verma: Today’s rule puts patients at the center in making the best decisions about their care.”
Today, the Centers for
Medicare & Medicaid Services (CMS) released a final rule that strengthens
the Medicare program by providing seniors more choices and lower cost options
in making the best decisions on their care. The policies adopted in the
Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical
Center (ASC) Payment System final rule with comment period will help lay the
foundation for a patient-driven healthcare system.
“President Trump is
committed to strengthening Medicare and lowering costs for patients. Today’s
rule advances competition by creating a level playing field for providers so
they can compete for patients on the basis of quality and care,” said CMS
Administrator Seema Verma. “The final policies remove unnecessary and
inefficient payment differences so patients can have more affordable choices
and options.”
To increase the
sustainability of the Medicare program and improve the quality of care for
patients, CMS is finalizing its proposed method to control unnecessary volume
increases for certain clinical visits by utilizing site-neutral payments for
these visits. This change will be phased in over two years. Clinic visits are
the most common service billed under the OPPS. Currently, CMS and
beneficiaries often pay more for the same type of clinic visit in the
hospital outpatient setting than in the physician office setting. This policy
would result in lower copayments for beneficiaries and savings for the
Medicare program in an estimated amount of $380 million for 2019. For
example, for a clinic visit furnished in an excepted off-campus PBD, average
beneficiary cost sharing is currently $23. Under this final rule, that cost
sharing would be reduced to $16 (based on a two year phase-in), saving
beneficiaries an average of $7 each time they visit an off-campus department
in CY 2019.
Additionally, CMS is
giving patients more options on where to obtain care by increasing the
services that can be furnished in ASCs. These changes are intended to help
improve access and convenience and ensure that CMS policies are not favoring
any particular provider type. For 2019, CMS is finalizing policies that will:
As part of the agency’s
“Patients Over Paperwork” Initiative—a cross-cutting process that evaluates
and streamlines regulations with the goal of reducing burden—CMS is
finalizing proposals to remove measures from the Hospital Outpatient Quality
Reporting Program and from the Ambulatory Surgery Center Quality Reporting
Program. These removals are aimed at enabling providers to focus on tracking
and reporting the measures that are most impactful on patient care. This
action will decrease burden for providers by approximately $27 million over
the next two years.
In 2018, CMS implemented a
payment policy to help beneficiaries save on coinsurance for drugs that were
administered at hospital outpatient departments that were acquired through
the 340B program—a program that allows certain hospitals to buy outpatient
drugs at lower cost. Due to CMS’ policy change, Medicare beneficiaries are
now benefitting from the discounts that 340B hospitals enjoy when they
receive 340B-acquired drugs. In 2018 alone, beneficiaries are saving an
estimated $320 million on out-of-pocket payments for these drugs. For 2019,
CMS is expanding on this policy by extending the 340B payment change to
additional off-campus provider-based hospital outpatient departments that are
paid under the Physician Fee Schedule.
In response to
recommendations from the President’s Commission on Combating Drug Addiction
and the Opioid Crisis, to comply with the requirements of the SUPPORT for
Patients and Communities Act (P.L. 115-271), and to avoid any potential
unintended consequences that would encourage overprescribing of opioids, CMS
is removing questions regarding pain communication from the hospital patient
experience survey. Additionally, CMS is adopting a policy to encourage
increased use of non-opioid drugs following a surgical procedure in the ASC
setting.
The President’s Commission
on Combating Drug Addiction and the Opioid Crisis also recommended that CMS
review its payment policies for certain drugs that function as a supply,
specifically non-opioid pain management treatments. Payment for drugs that
function as a supply in surgical procedures or diagnostic tests is packaged
under the OPPS and ASC payment systems. However, in response to this
recommendation as well as stakeholder comments and peer-reviewed evidence,
for 2019, CMS is finalizing the proposal to pay separately at Average Sales
Price plus 6 percent for non-opioid pain management drugs that function as a
supply when used in a covered surgical procedure performed in an ASC.
For a fact sheet on the CY
2019 OPPS and ASC Payment System final rule with comment period
(CMS-1695-FC), please visit: https://www.cms.gov/newsroom/fact-sheets/cms-finalizes-medicare-hospital-outpatient-prospective-payment-system-and-ambulatory-surgical-center.
The final rule can be
downloaded from the Federal
Register at: https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-24243.pdf.
###
Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on Twitter CMS
Administrator @SeemaCMS, @CMSgov, and @CMSgovPress.
|
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Friday, November 2, 2018
CMS Finalizes Rule that Encourages More Choices and Lower Costs for Seniors
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment